Reduced CPT1C expression levels were found to significantly increase the progression of the senescence phenotype in breast cancer cells by 13C-metabolic flux (13C-MFA) analysis, and stearate inhibited cell proliferation, whereas oleate reversed the silencing of the CPT1C-induced senescence phenotype [116]. Here, CPT1C is linked to breast carcinoma.